HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.

Abstract
We prospectively analysed the outcome after botulinum injection in patients who did not recover after conservative measures to manage masticatory myofascial pain, and who were not willing to take low dose tricyclic antidepressants as a muscle relaxant. We prospectively 62 patients were assessed with visual analogue scores (VAS) for pain on the affected side before, and 6 weeks after botulinum injection(s) (50 units Dysport in up to 3 sites), and measured mouth opening in mm. Of those treated 49 (79%) showed at least some improvement (pain reduced by more than 25%). Patients reported more than a 90% reduction in the VAS for 25 (30%) of the 84 sides of the face treated. Only 22 of the 62 patients had more than one course of treatment to the same side. Interincisal distance improved by a mean/median of 0.9 mm (p<0.03) after treatment. Side effects included 3 cases of temporary weakness of a facial muscle. Ranking the VAS pain scores using the Wilcoxon test before and after injection showed a significant reduction in pain (median change -29.5, interquartile range -53 to -16, p<0.0001). The treatment significantly improved patients' pain scores and the overall mean/median reduction in pain was 57%. Botulinum injection does not guarantee complete resolution of myofascial pain, but it usually has some beneficial effect in improving the symptoms, and should be considered as an alternate treatment for masticatory myofascial pain if conservative methods have failed.
AuthorsAndrew J Sidebottom, Amish A Patel, Janaki Amin
JournalThe British journal of oral & maxillofacial surgery (Br J Oral Maxillofac Surg) Vol. 51 Issue 3 Pg. 199-205 (Apr 2013) ISSN: 1532-1940 [Electronic] Scotland
PMID22871559 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2012 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Neuromuscular Agents
  • Botulinum Toxins, Type A
  • abobotulinumtoxinA
Topics
  • Adolescent
  • Adult
  • Aged
  • Botulinum Toxins, Type A (administration & dosage, therapeutic use)
  • Facial Muscles (drug effects)
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Intramuscular
  • Male
  • Masseter Muscle (drug effects)
  • Masticatory Muscles (drug effects)
  • Middle Aged
  • Muscle Weakness (chemically induced)
  • Neuromuscular Agents (administration & dosage, therapeutic use)
  • Pain Measurement
  • Prospective Studies
  • Pterygoid Muscles (drug effects)
  • Range of Motion, Articular (drug effects)
  • Temporal Muscle (drug effects)
  • Temporomandibular Joint Dysfunction Syndrome (drug therapy)
  • Treatment Outcome
  • Trigger Points
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: